EGFR activation is a potential determinant of primary resistance of hepatocellular carcinoma cells to sorafenib-Reference-Cited by-同舟云学术

EGFR activation is a potential determinant of primary resistance of hepatocellular carcinoma cells to sorafenib

Published:2012-04-30 Issue:12 Volume:131 Page:2961-2969
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Ezzoukhry Zakaria,Louandre Christophe,Trécherel Eric,Godin Corinne,Chauffert Bruno,Dupont Sébastien,Diouf Momar,Barbare Jean-Claude,Mazière Jean-Claude,Galmiche Antoine

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference34 articles.

1. Hepatocellular carcinoma;El-Serag;N Engl J Med,2011

2. Hepatocellular carcinoma: novel molecular approaches for diagnosis, prognosis, and therapy;Villanueva;Annu Rev Med,2010

3. Sorafenib in advanced hepatocellular carcinoma;Llovet;N Engl J Med,2008

4. Phase II study of sorafenib in patients with advanced hepatocellular carcinoma;Abou-Alfa;J Clin Oncol,2006

5. Selection of patients with hepatocellular carcinoma for sorafenib;Abou-Alfa;J Natl Compr Canc Networks,2009

Cited by 141 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted Therapies for Hepatocellular Carcinoma Treatment;Liver Cancer - Multidisciplinary Approach;2024-09-11

2. GATA4 downregulation enhances CCL20-mediated immunosuppression in hepatocellular carcinoma;Hepatology Communications;2024-08-19

3. Design, Synthesis and Evaluation of a Novel Teoptinib Derivative as an Effective Anti-hepatocellular Carcinoma Agent;Current Pharmaceutical Design;2024-08

4. Mechanisms of Sorafenib Resistance in HCC Culture Relate to the Impaired Membrane Expression of Organic Cation Transporter 1 (OCT1);Journal of Hepatocellular Carcinoma;2024-05

5. Comprehensive analysis of m6A modification in immune infiltration, metabolism and drug resistance in hepatocellular carcinoma;Cancer Cell International;2024-04-16